Design, synthesis and biological evaluation of novel, simplified analogues of laulimalide: modification of the side chain

Bioorganic & Medicinal Chemistry Letters
2005.0

Abstract

Novel, simplified analogues of the microtubule-stabilizing anticancer agent laulimalide, including the first derivatives with unnatural side chains, were designed by molecular modelling, synthesized by a late-stage diversification strategy, and evaluated in vitro for growth inhibition of human ovarian carcinoma cell lines (A2780, A2780/AD10).

Knowledge Graph

Similar Paper